TC
CORT icon

TownSquare Capital’s Corcept Therapeutics CORT Stock Holding History

TownSquare Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-135,698
Closed -$4.41M – 1499
2024
Q2 		$4.41M Buy
135,698
+18,565
+16% +$509K 0.06% 294
2024
Q1 		$2.95M Buy
+117,133
New +$2.77M 0.04% 366

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

TownSquare Capital's CORT Position: Q3 2024 in Review

TownSquare Capital sold out of Corcept Therapeutics (CORT) in Q3 2024, closing a stake of 135,698 shares — an estimated $4.41M sold.

TownSquare Capital first reported a position in CORT in Q1 2024 and held it in 2 quarters. The position peaked at $4.41M in Q2 2024. 321 funds tracked by Wall St. Rank hold CORT as of Q3 2024.

  • TownSquare Capital reported no remaining Corcept Therapeutics position as of Q3 2024 after selling out during the quarter.
  • TownSquare Capital sold 135,698 Corcept Therapeutics shares in Q3 2024, an estimated $4.41M.
  • TownSquare Capital first reported a position in Corcept Therapeutics in Q1 2024 and held it in 2 quarters.
  • TownSquare Capital's Corcept Therapeutics position peaked at $4.41M in Q2 2024.
  • 321 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2024.

Based on TownSquare Capital's 13F filing for Q3 2024, filed 13 Nov 2024.